Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M102,037Revenue (TTM) $M36,852Net Margin (%)2.5Altman Z-Score1.3
Enterprise Value $M126,046EPS (TTM) $0.2Operating Margin %7.5Piotroski F-Score4
P/E(ttm)112Beneish M-Score-2.6Pre-tax Margin (%)4.7Higher ROA y-yN
Price/Book25.210-y EBITDA Growth Rate %0.3Quick Ratio0.8Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %-5.1Current Ratio1.1Lower Leverage y-yY
Price/Free Cash Flow131y-y EBITDA Growth Rate %-73.8ROA % (ttm)1.1Higher Current Ratio y-yN
Dividend Yield %5.6PEG--ROE % (ttm)11.1Less Shares Outstanding y-yN
Payout Ratio %637Shares Outstanding M4,871ROIC % (ttm)7.7Gross Margin Increase y-yN

Gurus Latest Trades with GLAXF

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

GLAXF is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


GLAXF: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$22-4.77view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.14-0.9view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29296.03view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$1274.58view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$1449.64view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$1274.58view

Quarterly/Annual Reports about GLAXF:

    News about GLAXF:

    Articles On GuruFocus.com
    PhaseRX: The Latest Pick From a Legendary VC Firm May 24 2016 
    Kahn Brothers Adds to BP, GlaxoSmithKline Stakes May 10 2016 
    A Closer Look Into Veritas Pharma Apr 21 2016 
    Dividend and Value Opportunities in the Large-Cap Pharmaceutical Space Apr 05 2016 
    Why the UK Is Headed For a Slowdown Mar 23 2016 
    Insiders Roundup: Theravance Biopharma, Western Gas, Upland Software Mar 18 2016 
    Brandes Makes a Variety of Reductions in 4th Quarter Feb 11 2016 
    10 Fund Managers Are Totally Wrong on GlaxoSmithKline Jan 26 2016 
    Stocks Bring High Dividend Yields to HOTCHKIS & WILEY Jan 14 2016 
    Jeff Auxier's Holdings Trading Below Peter Lynch Earnings Line Jan 04 2016 

    More From Other Websites
    New incentives needed to develop antibiotics to fight superbugs May 27 2016
    GSK gets EU approval for first gene therapy for children May 27 2016
    GSK gets EU approval for first gene therapy for children May 27 2016
    GSK gets EU approval for first gene therapy for children May 27 2016
    Ionis Down, Glaxo Dumps IONIS-TTRRx Phase III Study Plans May 27 2016
    Lloyds Banking Group plc vs GlaxoSmithKline plc: which is the better growth stock? May 27 2016
    There has never been a better time to buy GlaxoSmithKline plc, Persimmon plc and Admiral Group plc May 27 2016
    China regulator to launch drug pricing probe in June May 26 2016
    Ionis Hits 3-Year Low As GlaxoSmithKline Drops Big Trial Plans May 26 2016
    Ionis shares plummet as GSK scraps heart drug trial plans May 26 2016
    [$$] Ionis's Shares Fall After Co-Developer Opts Against Starting Late-Stage Trial May 26 2016
    Why Ionis Pharmaceuticals (IONS) Stock Is Tanking Today May 26 2016
    Ionis Pharmaceuticals Inc (IONS) Plunges After GSK Foregos Phase 3 Study of TTRRx May 26 2016
    Glaxo/Innoviva Report Positive COPD Data on Relvar Ellipta May 25 2016
    Is GlaxoSmithKline plc a better dividend buy than Standard Life plc and Legal & General Group plc? May 25 2016
    Why this GSK news is good for workers in Zebulon May 24 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)